Vanguard Value Index Fund ETF vs GeneDx Holdings Corp — how do they compare? Vanguard Value Index Fund ETF trades at $218.54, while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). The key difference: Vanguard Value Index Fund ETF is trading nearer its 52-week high, GeneDx Holdings Corp nearer its low. Which is the better fit depends on your goals.
| VTV | WGS | |
|---|---|---|
52-Week High | $220.51 | $167.51 |
52-Week Low | $175.51 | $34.51 |
Market Cap | — | $1.80B |
Sector | — | Technology |
Enterprise Value | — | $1.80B |
Trailing returns across standard periods
The fund employs an indexing investment approach designed to track the performance of the CRSP US Large Cap Value Index, a broadly diversified index predominantly made up of value stocks of large US companies. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Read more on VTV →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →